Policy Cures Research release new data on the impact of global health R&D newsghana.com.gh - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsghana.com.gh Daily Mail and Mail on Sunday newspapers.
Investment in research to tackle poverty-related and neglected diseases – such as TB and malaria – has fallen since the COVID-19 pandemic, according to Andrew Tuttle, chief strategy officer of Policy Cures Research. After rising steadily, annual investment in such research began to plateau in 2018 and then declined in the wake of the pandemic, he told a session entitled Deepening cooperation with the Global South for sustainable health futures at the Science|Business Annual Conference, organised in partner
Congressman Brian Fitzpatrick (PA-01), Congresswoman María Elvira Salazar (FL-27), and Congresswoman Chrissy Houlahan (PA-06) introduced the Supporting Innovative Global Health Technologies (SIGHT) Act of 2023, which would establish a disease-agnostic research and development program at the US Agency for International Development in the House of Representatives.